Increased activation of the PI3K/AKT pathway conferred cisplatin resistance in an ovarian cancer cell line,[27] implicating the PI3K/AKT pathway in ovarian cancer cell survival and evasion of apoptosis. Here, AKT1 is linked to ovarian carcinoma.